Documents Médias Positive Phase 2 Study Results for Tivantinib in Previously Treated Hepatocellular Carcinoma Presented at ASCO
Documents Médias Daiichi Sankyo y arqule presentan resultados de un estudio Fase II de tivantinib en Carcinoma Hepatocelular
Documents Médias Positive Phase 2 Study Results for Tivantinib in Previously Treated Hepatocellular Carcinoma to be Presented at ASCO
